Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,734 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 3,532 of 4,734    |
|    =?UTF-8?B?4oqZ77y/4oqZ?= to All    |
|    Reduced Glucose Uptake in Brain Exacerba    |
|    13 Mar 15 14:07:16    |
      From: hounddog23x@gmail.com              Alzheimers News Today              Reduced Glucose Uptake in Brain Exacerbates Alzheimer’s Disease Symptoms              MARCH 11TH, 2015 Daniela Semedo, PhD DANIELA SEMEDO, PHD ALZHEIMER'S NEWS,       NEWS 0 COMMENTS       brainAccording to a recent study from researchers at the Keck School of       Medicine of the University of Southern California, reduced expression of a       protein called GLUT1, responsible for moving glucose in the brain-blood       barrier (BBB) worsens Alzheimer’s        disease cerebrovascular degeneration, neuropathology and cognitive function,       suggesting that GLUT1 may represent a therapeutic target for Alzheimer’s       disease vasculo-neuronal dysfunction and degeneration. The study titled       “GLUT1 reductions exacerbate        Alzheimer’s disease vasculo-neuronal dysfunction and degeneration,” was       published online this week in peer-reviewed scientific journal Nature       Neuroscience.              “Our results suggest that GLUT1 deficiencies at the blood-brain barrier are       not just symptoms of Alzheimer’s but, in fact, lead to a series of vascular       injuries that worsen the effects of the disease,” said Berislav V. Zlokovic,       M.D., Ph.D.,        director of the Zilkha Neurogenetic Institute (ZNI) at the Keck School of       Medicine, the Mary Hayley and Selim Zilkha Chair for Alzheimer’s Disease       Research and the study’s principal investigator. “We do not know yet       whether medicine can restore        GLUT1 expression, but we believe that targeting the protein may help prevent       Alzheimer’s from getting worse among individuals predisposed to develop the       disease.”              Estimates for Alzheimer’s disease show that the condition affects       approximately 5.2 million people of all ages in the United States, and       researchers believe that the disease will affect 16 million Americans aged       over 65 years by 2050. Alzheimer’s        disease causes progressive and irreversible memory, thinking and behavior       impairments. GLUT1 helps glucose, the brains energy source, to move across the       BBB, a layer in the brain that averts the entry of pathogens and blood into       the brain.              For the study, the research team found that GLUT1 insufficiency caused reduced       glucose uptake in mice over expressing amyloid β-peptide (Aβ) leading to       diminished neuronal activity, behavioral deficits, and progressive neuronal       loss and        neurodegeneration,              Results also revealed that GLUT1 deficiency in endothelium, but not in       astrocytes, initiates the vascular phenotype as shown by BBB breakdown.       Alzheimer’s disease occurs due to accumulation of amyloid-beta peptide in       the brain facilitated by breakdown        of the BBB. Future studies could involve the identification of the metabolic       pathways by which GLUT1 deficits influence metabolism and if early embryonic       GLUT1 damage disturbs the central nervous system differently than a defect       experienced later during        development.              http://alzheimersnewstoday.com/2015/03/11/reduced-glucose-uptake       in-brain-exacerbates-alzheimers-disease-symptoms/              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca